Pharmaceutical grad CBD and metabolites
Active Purchase Order Awarded Last action
- Contract number
- 75F40126P00209
- Awardee
-
Cayman Chemical Co Inc. UEI T1ZHJRGR7TF4
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $20,300
Award facts
- Contract value 100% obligated
- $20,300.00 Current and potential, with all options
- Completion date 89% complete
- Current and potential, with all options
- NAICS code
- 325199 All Other Basic Organic Chemical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Ann Arbor, MI 48108, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a purchase order to Cayman Chemical Co Inc. for pharmaceutical-grade CBD and metabolites on August 11, 2026, with a ceiling value of $20,300.00 and an ultimate completion date of October 31, 2026. Place of performance is Ann Arbor, Michigan. The order is firm fixed price with no set-aside applied.
Quick answers
Who was awarded contract 75F40126P00209?
75F40126P00209 was awarded to Cayman Chemical Co Inc. by Food and Drug Administration (Department of Health and Human Services) on August 11, 2026.
How much is contract 75F40126P00209 worth?
The government has obligated $20,300 on 75F40126P00209.
Was contract 75F40126P00209 competed?
The extent of competition for 75F40126P00209 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award